Cost of Goods Analysis Facilitates an Integrated Approach to Identifying Alternative Synthesis Methodologies for Lower Cost Manufacturing of the COVID-19 Antiviral Molnupiravir [version 1; peer review: 2 approved]

Cost of Goods Analysis Facilitates an Integrated Approach to Identifying Alternative Synthesis Methodologies for Lower Cost Manufacturing of the COVID-19 Antiviral Molnupiravir [version 1; peer review: 2 approved]

Orally delivered drugs offer significant benefits in the fight against viral infections, and cost-effective production is critical to their impact on pandemic response in low- and middle-income countries. One example, molnupiravir, a COVID-19 therapy developed by Emory, Ridgeback, and Merck & Co...

Full description

Bibliographic Details
Main Authors: Christopher Peterson, Anita Deshpande, Sayan Paria, Andrew Harmon, Saeed Ahmad, Trevor Laird, John Dillon
Format: Article
Language:English
Published: F1000 Research Ltd 2022-02-01
Series:Gates Open Research
Subjects:
molnupiravir
uridine
cytidine
COVID-19
SARS-CoV-2
coronavirus
eng
Online Access:https://gatesopenresearch.org/articles/6-8/v1

Internet

https://gatesopenresearch.org/articles/6-8/v1

Similar Items